Zhejiang Haisen Pharmaceutical Co., Ltd. (SHE:001367)
China flag China · Delayed Price · Currency is CNY
25.92
-0.50 (-1.89%)
At close: Apr 15, 2026

SHE:001367 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
3,8973,3002,7962,989--
Market Cap Growth
38.29%18.01%-6.46%---
Enterprise Value
2,8432,3001,8322,063--
Last Close Price
25.9221.9518.3019.69--
PE Ratio
29.1224.2922.8228.56--
PS Ratio
7.326.205.937.52--
PB Ratio
2.612.212.082.39--
P/TBV Ratio
2.832.402.112.43--
P/FCF Ratio
154.69131.0027.31128.99--
P/OCF Ratio
21.9618.6016.7337.08--
EV/Sales Ratio
5.344.323.895.19--
EV/EBITDA Ratio
17.1514.0013.8718.18--
EV/EBIT Ratio
19.9416.1315.7020.45--
EV/FCF Ratio
112.8691.2917.8989.04--
Debt / Equity Ratio
0.010.010.0100.000.00
Debt / EBITDA Ratio
0.040.040.060.000.010.01
Debt / FCF Ratio
0.300.300.080.010.010.02
Net Debt / Equity Ratio
-0.70-0.70-0.76-0.75-0.52-0.57
Net Debt / EBITDA Ratio
-6.41-6.41-7.77-8.31-2.08-1.74
Net Debt / FCF Ratio
-41.83-41.83-10.02-40.72-4.50-2.77
Asset Turnover
0.340.340.330.420.810.93
Inventory Turnover
2.602.602.051.572.152.47
Quick Ratio
10.0610.069.3312.903.532.46
Current Ratio
11.0111.0110.3114.955.353.51
Return on Equity (ROE)
9.58%9.58%9.45%12.18%25.91%29.36%
Return on Assets (ROA)
5.72%5.72%5.16%6.62%12.59%15.61%
Return on Invested Capital (ROIC)
28.36%32.62%32.36%33.13%48.12%61.17%
Return on Capital Employed (ROCE)
9.40%9.40%8.60%8.00%21.80%28.00%
Earnings Yield
3.49%4.12%4.38%3.50%--
FCF Yield
0.65%0.76%3.66%0.78%--
Dividend Yield
0.44%0.53%0.93%1.16%--
Payout Ratio
12.84%12.84%27.74%-0.66%17.48%
Buyback Yield / Dilution
-2.15%-2.15%-9.03%-22.74%0.02%-
Total Shareholder Return
-1.71%-1.62%-8.10%-21.58%0.02%-
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.